Luseogliflozin regulatory update

Last month, Taisho's Taisho Pharmaceutical Co. Ltd. subsidiary submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for luseogliflozin (TS-071) to treat Type II ...